{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:01:15Z","timestamp":1761166875318,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2003]]},"DOI":"10.1385\/jcd:6:1:45","type":"journal-article","created":{"date-parts":[[2003,11,17]],"date-time":"2003-11-17T13:42:43Z","timestamp":1069076563000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Bone Density Changes with Once Weekly Risedronate in Postmenopausal Women"],"prefix":"10.1016","volume":"6","author":[{"given":"Miriam F.","family":"Delaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaclyn","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meryl S.","family":"LeBoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1385\/JCD:6:1:45_bib1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with post menopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1385\/JCD:6:1:45_bib2","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0149-2918(00)83042-8","article-title":"Rechallenge of patients who had discontinued alendronate therapy because of upper gastrointestinal symptoms","volume":"22","author":"Miller","year":"2000","journal-title":"Clin Ther"},{"key":"10.1385\/JCD:6:1:45_bib3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0149-2918(00)87974-6","article-title":"Weekly administration of alendronate: rationale and plan for clinical assessment","volume":"22","author":"Bone","year":"2000","journal-title":"Clin Ther"},{"key":"10.1385\/JCD:6:1:45_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03339822","article-title":"Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis","volume":"12","author":"Schnitzer","year":"2000","journal-title":"Aging Clin Exp Res"},{"key":"10.1385\/JCD:6:1:45_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/00912700022008928","article-title":"Dose-proportional pharmacokinetics of risedronate on single-dose oral administration to healthy volunteers","volume":"40","author":"Mitchell","year":"2000","journal-title":"Clin Pharmacol"},{"key":"10.1385\/JCD:6:1:45_bib6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1053\/gast.2000.16517","article-title":"Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women","volume":"119","author":"Lanza","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1385\/JCD:6:1:45_bib7","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1023\/A:1018894827961","article-title":"Esophageal irritation due to alendronate sodium tablets: possible mechanisms","volume":"43","author":"Peter","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1385\/JCD:6:1:45_bib8","first-page":"396","article-title":"Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up","volume":"83","author":"Mortensen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1385\/JCD:6:1:45_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1385\/JCD:6:1:45_bib10","first-page":"3109","article-title":"Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women","volume":"85","author":"Tonino","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1385\/JCD:6:1:45_bib11","first-page":"1895","article-title":"Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial","volume":"85","author":"Fogelman","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1385\/JCD:6:1:45_bib12","article-title":"Similar gastrointestinal side effects and endoscopic finding between risedronate and placebo-treated patients","author":"Hosking","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1385\/JCD:6:1:45_bib13","article-title":"Risedronate 30 mg administered once weekly in the treatment of postmenopausal osteoporosis","author":"Miller","year":"2002","journal-title":"Current Therapeutics"},{"key":"10.1385\/JCD:6:1:45_bib14","first-page":"3076","article-title":"Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: a randomized, controlled clinical trial","volume":"84","author":"Lindsay","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1385\/JCD:6:1:45_bib15","first-page":"S1100","article-title":"Effects of raloxifene (RLX), alendronate (ALN) and RLX + ALN on bone mineral density (BMD) and biochemical markers of bone turnover in postmenopausal women with osteoporosis","volume":"14","author":"Johnell","year":"1999","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695006602527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695006602527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:33:37Z","timestamp":1761082417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695006602527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003]]}},"alternative-id":["S1094695006602527"],"URL":"https:\/\/doi.org\/10.1385\/jcd:6:1:45","relation":{},"ISSN":["1094-6950"],"issn-type":[{"type":"print","value":"1094-6950"}],"subject":[],"published":{"date-parts":[[2003]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone Density Changes with Once Weekly Risedronate in Postmenopausal Women","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1385\/JCD:6:1:45","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}